7Baggers
Quarterly
Annual
    Unit: USD2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 
                         
      cash flows from operating activities:
    		                     
      net loss
    		-309,550,000 -291,603,000 -297,930,000 -429,952,000 -325,724,000 -327,902,000 -317,770,000 -317,816,000 -169,912,000 -214,694,000 -227,320,000 -226,064,000 -207,484,000 -201,442,000 -222,806,000 -165,794,000 -132,153,000 -154,856,000 -189,719,000 -203,220,000 -198,935,000 
      adjustments to reconcile net loss to net cash from operating activities:
    		                     
      depreciation and amortization
    		58,924,000 57,878,000 54,837,000 48,804,000 50,130,000 47,046,000 45,111,000 40,221,000 34,986,000 32,470,000 29,284,000 23,163,000 19,726,000 17,696,000 16,172,000 9,941,000 5,912,000 5,518,000 5,384,000 4,684,000 3,215,000 
      non-cash operating lease costs
    		16,701,000 15,764,000 16,156,000 17,842,000 17,573,000 14,802,000 13,846,000 13,722,000 13,751,000 13,488,000 12,784,000 12,869,000 12,661,000 12,340,000 11,148,000 10,091,000 9,658,000 8,855,000 8,531,000 8,509,000 8,635,000 
      amortization of deferred commissions
    		45,003,000 36,458,000 33,158,000 25,796,000 24,293,000 23,249,000 22,822,000 22,764,000 20,065,000 18,869,000 18,181,000 17,672,000 15,920,000 14,554,000 13,770,000 13,201,000 11,052,000 9,667,000 8,841,000 8,316,000 7,608,000 
      stock-based compensation, net of amounts capitalized
    		403,592,000 412,278,000 404,217,000 379,460,000 428,119,000 363,259,000 356,000,000 331,936,000 305,498,000 298,286,000 299,722,000 264,509,000 250,696,000 229,163,000 209,181,000 172,493,000 145,703,000 144,387,000 163,991,000 151,014,000 143,651,000 
      net accretion of discounts on investments
    		-3,344,000 -5,100,000 -5,717,000 -7,652,000  -9,097,000 -12,780,000 -11,992,000              
      net realized and unrealized losses on strategic investments in equity securities
    		24,375,000 255,000 5,580,000 29,685,000 -4,394,000 8,611,000 6,508,000 20,695,000              
      amortization of debt issuance costs
    		2,078,000 2,075,000 2,074,000 2,071,000 2,070,000                 
      asset impairment related to office facility exit
    		0 96,000 2,131,000 106,488,000                  
      deferred income tax
    		1,108,000 0   -7,139,000 -581,000   -13,655,000 -213,000 -4,026,000 -8,868,000 -1,387,000 1,387,000 0 -26,664,000      
      non-cash restructuring charges (recoveries)
    		0                     
      other
    		1,023,000 1,216,000 1,685,000 -5,174,000 2,541,000 2,961,000 1,249,000 669,000 609,000 2,474,000 1,834,000 9,978,000 940,000 -1,396,000 313,000 1,761,000 -1,238,000 -247,000 1,568,000 1,214,000 507,000 
      changes in operating assets and liabilities, net of effects of business combinations:
    		                     
      accounts receivable
    		-367,344,000 -288,676,000 -117,606,000 393,657,000 -328,168,000 -163,488,000 -87,127,000 579,319,000 -417,221,000 -104,705,000 -53,050,000 362,893,000 -317,688,000 -88,846,000 -27,087,000 266,656,000 -290,794,000 -16,754,000 -71,283,000 127,179,000 -125,510,000 
      deferred commissions
    		-123,383,000 -96,816,000 -53,750,000 -31,114,000 -38,784,000 -26,031,000 -21,814,000 -14,940,000 -68,317,000 -25,478,000 -24,552,000 -16,440,000 -31,480,000 -23,721,000 -23,188,000 -16,718,000 -42,985,000 -18,961,000 -19,182,000 -14,749,000 -24,183,000 
      prepaid expenses and other assets
    		-42,001,000 19,823,000 -4,486,000 -17,852,000 -12,606,000 9,109,000 34,458,000 -1,111,000 8,221,000 4,658,000 41,389,000 5,527,000 -16,073,000 41,346,000 29,358,000 -57,535,000 -46,361,000 -42,710,000 -15,731,000 -54,357,000 -32,869,000 
      accounts payable
    		-44,595,000 28,948,000 11,771,000 -4,423,000 6,131,000 11,296,000 70,181,000 21,244,000 -32,460,000 34,203,000 20,562,000 -3,093,000 -2,280,000 4,079,000 2,067,000 4,158,000 2,780,000 869,000 4,967,000 -1,245,000 928,000 
      accrued expenses and other liabilities
    		175,491,000 120,620,000 93,291,000 3,935,000 32,174,000 34,065,000 59,325,000 -54,688,000 137,339,000 6,603,000 35,648,000 -8,542,000 46,792,000 17,272,000 24,672,000 -14,217,000 36,666,000 19,386,000 30,287,000 -6,567,000 35,775,000 
      operating lease liabilities
    		15,438,000 -15,990,000 -14,559,000 -11,838,000 -13,367,000 -9,055,000 -11,915,000 -13,374,000 -11,759,000 -12,716,000 -5,260,000 -10,763,000 -13,166,000 -10,990,000 -9,810,000 -8,376,000 -13,491,000 -8,766,000 -8,159,000 -7,833,000 -7,863,000 
      deferred revenue
    		927,638,000 151,452,000 -52,511,000 -271,360,000 609,441,000 122,773,000 -88,278,000 -261,181,000 595,438,000 82,106,000 -39,035,000 -110,480,000 467,634,000 55,316,000 12,792,000 -21,441,000 402,191,000 58,018,000 70,122,000 -4,110,000 201,142,000 
      net cash from operating activities
    		781,154,000 137,519,000 74,896,000 228,373,000 432,725,000 101,706,000 69,865,000 355,468,000 344,580,000 120,907,000 83,191,000 299,444,000 217,316,000 79,277,000 64,433,000 184,613,000 78,898,000 15,538,000 -6,111,000 21,854,000 19,614,000 
      capital expenditures
    		-16,069,000 -23,905,000 -16,665,000  -17,282,000 -23,472,000 -11,035,000 -23,923,000 -20,101,000 -18,635,000 -14,172,000 -16,311,000 -12,055,000 -14,284,000 -10,584,000 -12,217,000 -8,172,000 -6,070,000 -5,841,000 -8,910,000 -12,298,000 
      free cash flows
    		765,085,000 113,614,000 58,231,000  415,443,000 78,234,000 58,830,000 331,545,000 324,479,000 102,272,000 69,019,000 283,133,000 205,261,000 64,993,000 53,849,000 172,396,000 70,726,000 9,468,000 -11,952,000 12,944,000 7,316,000 
      cash flows from investing activities:
    		                     
      purchases of property and equipment
    		-16,069,000 -23,905,000 -16,665,000 -44,989,000 -11,277,000 -13,440,000 -5,043,000 -16,519,000 -13,072,000 -8,746,000 -6,298,000 -6,970,000 -5,362,000 -8,505,000 -3,848,000 -7,413,000 -4,012,000 -2,282,000 -3,497,000 -6,430,000 -11,019,000 
      capitalized software development costs
    		                     
      cash paid for business combinations, net of cash, cash equivalents, and restricted cash acquired
    		    -13,180,000 -8,219,000   3,828,000 -14,963,000 -141,459,000 -123,112,000          
      purchases of intangible assets
    		-1,790,000 0       0 -1,264,000   0 0   -13,152,000 0 -722,000 -10,460,000 -2,190,000 
      purchases of investments
    		-50,204,000 -341,172,000 -636,469,000 -1,012,575,000 -280,258,000 -1,014,243,000 -196,481,000 -1,078,261,000 -380,877,000 -369,365,000 -688,678,000 -1,037,286,000 -1,105,154,000 -870,910,000 -1,027,966,000 -897,291,000 -1,207,942,000 -1,053,763,000 -842,963,000 -1,145,670,000 -3,624,832,000 
      sales of investments
    		1,806,000 522,000 1,476,000 17,399,000 10,179,000 13,597,000 10,437,000 30,360,000 0 4,000,000 1,614,000 5,652,000 0 14,881,000 32,958,000 10,974,000 33,066,000 14,691,000 7,929,000 384,383,000 148,365,000 
      maturities and redemptions of investments
    		500,114,000 612,794,000 517,947,000 984,182,000 525,429,000 765,195,000 590,063,000 921,395,000 919,719,000 971,087,000 971,217,000 808,844,000 1,062,479,000 898,081,000 809,845,000 886,667,000 1,232,367,000 1,216,206,000 877,635,000 516,588,000 329,348,000 
      settlement of cash flow hedges
    		    0 0 0 -749,000              
      net cash from investing activities
    		419,237,000 248,239,000 -299,252,000 -55,983,000 224,888,000 -267,142,000 384,078,000 -151,178,000 522,569,000 570,860,000 101,042,000 -362,213,000 -64,784,000 -146,862,000 -196,447,000 -189,792,000 36,167,000 171,064,000 36,038,000 -264,069,000 -3,161,607,000 
      cash flows from financing activities:
    		                     
      proceeds from exercise of stock options
    		20,835,000 28,849,000 28,186,000 6,260,000 9,674,000 11,548,000 12,978,000 10,686,000 18,340,000 7,335,000 16,149,000 15,370,000 8,798,000 7,299,000 8,520,000 15,276,000 36,592,000 24,579,000 24,463,000 41,402,000 22,278,000 
      proceeds from issuance of common stock under employee stock purchase plan
    		0 34,930,000 0 53,193,000 0 30,318,000 0 46,735,000 0 24,169,000 0 37,065,000 0 14,837,000 0 26,094,000      
      taxes paid related to net share settlement of equity awards
    		-187,646,000 -190,724,000 -161,999,000 -132,498,000 -129,542,000 -81,493,000 -103,524,000 -174,590,000 -106,971,000 -91,118,000 -98,311,000 -84,399,000 -48,882,000 -51,657,000 -30,893,000 -53,216,000      
      repurchases of common stock
    		-150,003,000 -232,896,000 0 -490,638,000 0 -1,016,004,000 -400,000,000 -516,329,000 0 -400,038,000 0 -191,694,000          
      distributions to noncontrolling interest holders
    		-7,150,000                     
      payments of deferred purchase consideration for business combinations
    		-1,344,000 0                    
      gross proceeds from issuance of convertible senior notes
    		    0                 
      cash paid for issuance costs on convertible senior notes
    		    0                 
      purchases of capped calls related to convertible senior notes
    		    0                 
      net cash from financing activities
    		-325,308,000 -361,986,000 -134,039,000 -564,057,000 -120,118,000 1,017,639,000 -490,546,000 -633,498,000 -88,631,000 -459,652,000 -82,162,000 -223,658,000 -40,084,000 -18,321,000 -22,373,000 -11,846,000 35,527,000 50,408,000 24,463,000 67,800,000 22,278,000 
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		4,589,000 21,000 -175,000 12,397,000 -5,055,000 778,000 724,000 -2,633,000 2,564,000 -5,600,000 470,000 535,000 8,457,000 -2,002,000 -2,290,000 -5,098,000 -257,000 -194,000    
      net increase in cash, cash equivalents, and restricted cash
    		879,672,000    532,440,000    781,082,000    120,905,000    150,335,000 236,816,000 54,586,000 -174,396,000  
      cash, cash equivalents, and restricted cash—beginning of period
    		0 0 0 2,698,678,000 0 0 0 1,780,977,000 0 0 0 956,731,000 0 0 0 1,102,534,000 0 0 0 835,193,000  
      cash, cash equivalents, and restricted cash—end of period
    		879,672,000 23,793,000 -358,570,000 2,319,408,000 532,440,000 852,981,000 -35,879,000 1,349,136,000 781,082,000 226,515,000 102,541,000 670,839,000 120,905,000 -87,908,000 -156,677,000 1,080,411,000 150,335,000 236,816,000 54,586,000 660,797,000  
      supplemental disclosures of non-cash investing and financing activities
    		                     
      property and equipment included in accounts payable and accrued expenses
    		-6,069,000 -12,117,000 3,208,000 32,184,000 14,863,000 1,030,000 3,375,000 16,793,000 9,773,000 1,216,000 -1,597,000 8,071,000 476,000 180,000   2,000,000 1,925,000 -2,279,000 3,469,000 4,138,000 
      stock-based compensation included in capitalized software development costs
    		     11,940,000 7,846,000 9,295,000 10,951,000 12,608,000 12,903,000 11,719,000 8,172,000 7,515,000   4,697,000 5,865,000 6,848,000 6,210,000  
      issuance of common stock in connection with business combinations
    		                     
      reconciliation of cash, cash equivalents, and restricted cash:
    		                     
      cash and cash equivalents
    		886,506,000 60,937,000 -362,363,000 2,243,083,000 479,870,000 866,883,000 -48,366,000 1,330,411,000 780,567,000 226,990,000 102,178,000 653,014,000 120,899,000 -87,660,000   150,512,000 236,669,000 53,874,000 644,674,000 -3,119,748,000 
      restricted cash—included in other assets and prepaid expenses and other current assets
    		-6,834,000 -37,144,000 3,793,000 76,325,000 52,570,000 -13,902,000 12,487,000 18,725,000 515,000 -475,000 363,000 17,825,000 6,000 -248,000        
      total cash, cash equivalents, and restricted cash
    		879,672,000 23,793,000 -358,570,000 2,319,408,000 532,440,000 852,981,000 -35,879,000 1,349,136,000 781,082,000 226,515,000 102,541,000 670,839,000 120,905,000 -87,908,000   150,335,000 236,816,000    
      cash paid for business combinations, net of cash acquired
    		 0                    
      supplemental disclosures of non-cash investing and financing activities:
    		                     
      unpaid taxes related to net share settlement of equity awards included in accrued expenses and other current liabilities
    		 -1,932,000 4,138,000 6,109,000 3,835,000 -1,281,000 -4,635,000 9,354,000 1,557,000 -956,000 1,592,000 4,657,000  849,000        
      net decrease in cash, cash equivalents, and restricted cash
    		  -358,570,000 -379,270,000   -35,879,000 -431,841,000   102,541,000 -285,892,000   -156,677,000 -22,123,000      
      changes in operating assets and liabilities:
    		                     
      capitalized internal-use software development costs
    		    -6,005,000 -10,032,000 -5,992,000 -7,404,000 -7,029,000 -9,889,000 -7,874,000 -9,341,000 -6,693,000 -5,779,000 -6,736,000 -4,804,000 -4,160,000 -3,788,000 -2,344,000 -2,480,000 -1,279,000 
      payments of deferred purchase consideration for a business combination
    		   -374,000                  
      stock-based compensation included in capitalized internal-use software development costs
    		                     
      net amortization of premiums on investments
    		        -12,299,000 -16,234,000 -17,661,000 -15,331,000 -8,834,000 -545,000 4,678,000 8,198,000 11,064,000 11,587,000 12,332,000 13,019,000 7,513,000 
      capital contributions from noncontrolling interest holders
    		            0         
      supplemental disclosures of cash flow information:
    		                     
      cash paid for income taxes
    		                    570,000 
      net unrealized losses on strategic investments in equity securities
    		         1,790,000 -5,309,000 2,414,000 1,339,000 13,064,000        
      issuance of common stock in connection with a business combination
    		            0 0        
      cash paid for business combinations, net of cash and cash equivalents acquired
    		            -10,054,000         
      proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
    		                    0 
      proceeds from initial public offering and private placements, net of underwriting discounts
    		                    0 
      proceeds from early exercised stock options
    		                    0 
      proceeds from repayments of a nonrecourse promissory note
    		                    0 
      repurchases of early exercised stock options
    		                     
      vesting of early exercised stock options
    		                     
      purchases of intangible assets included in accrued expenses and other liabilities
    		                     
      changes in operating assets and liabilities, net of effects of a business combination:
    		                     
      cash paid for a business combination, net of cash and cash equivalents acquired
    		              0 -177,925,000      
      net unrealized losses on strategic investments in marketable equity securities
    		               8,859,000      
      net unrealized gains on strategic investments in equity securities
    		                     
      changes in operating assets and liabilities, net of effect of business combinations:
    		                     
      repurchases of early exercised stock options and restricted common stock
    		                    0 
      vesting of early exercised stock options and restricted common stock
    		                135,000    251,000 
      equity consideration in connection with a business combination
    		                     
      intangible assets included in accrued expenses and other liabilities
    		                0 0 -495,000 5,039,000  
      net change in unrealized gains or losses on available-for-sale debt securities
    		                     
      unrealized gains on strategic investments in equity securities
    		                     
      proceeds from issuance of common stock under the employee stock purchase plan
    		                 25,829,000 0 26,398,000  
      restricted cash – included in other assets and prepaid expenses and other current assets
    		                 147,000 712,000 16,123,000 22,000 
      unrealized gains on strategic investments in privately-held equity securities
    		                     
      payments of deferred offering costs
    		                     
      payment of deferred purchase consideration for a business combination
    		                     
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		                   19,000  
      reconciliation of cash, cash equivalents and restricted cash:
    		                     
      total cash, cash equivalents and restricted cash
    		                   660,797,000 -3,119,726,000 
      changes in operating assets and liabilities, net of effect of acquisitions:
    		                     
      cash paid for acquisitions, net of cash acquired
    		                    0 
      repurchases of common stock in connection with issuer tender offers
    		                     
      payments of deferred purchase consideration for acquisitions
    		                    0 
      net increase in cash, cash equivalents and restricted cash
    		                     
      cash, cash equivalents and restricted cash—beginning of period
    		                     
      cash, cash equivalents and restricted cash—end of period
    		                     
      deferred purchase consideration for acquisitions
    		                    0 
      equity consideration in connection with an acquisition
    		                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.